SBIR Phase II: nCapsule Personalized Cancer Screening for Colorectal Cancer Treatment Regi — NSF Award to ENCAPSULATE LLC (CT, $1,
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project lies in its ability to transform personalized cancer treatment by providing a rapid and precise method for predicting the effectiveness of various treatment options on individual patients. Current treatment select
| Award title | SBIR Phase II: nCapsule Personalized Cancer Screening for Colorectal Cancer Treatment Regi |
|---|---|
| Award ID | 2436609 |
| Awardee | ENCAPSULATE LLC |
| City | FARMINGTON |
| State | CT |
| Amount obligated | $1,213,619 |
| Principal investigator | Armin Rad |
| Program | SBIR Phase II |
| Start date | 06/15/2025 |
| Abstract | The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project lies in its ability to transform personalized cancer treatment by providing a rapid and precise method for predicting the effectiveness of various treatment options on individual patients. Current treatment selection methods rely on an empirical, trial-and-error approach, often resulting in unnecessary toxicity, increased healthcare costs, and suboptimal patient outcomes. This project seeks |
| Source | NSF Awards |
$799/mo
Try NSFGrants →